{ "$schema": "https://augustgp.com/data/news.schema.json", "generated_at": "2026-08-27", "publisher": { "name": "August Global Partners", "url": "https://augustgp.com", "email": "admin@augustgp.com" }, "items": [ { "date": "2026-08-24", "month_label": "August 2026", "source": "Business Wire", "title": "Shape Memory Medical Secures $10M Financing Led by AGP to Advance Aortic Clinical Programs", "url": "https://www.businesswire.com/news/home/20260823384967/en/Shape-Memory-Medical-Secures-%2410-Million-Financing-Led-by-August-Global-Partners-to-Advance-Aortic-Clinical-Programs", "summary": "AGP leads a $10M convertible note financing in Shape Memory Medical, a California-based medical device company developing proprietary shape memory polymer technology for endovascular embolization, with participation from Taiwania Capital and support from HEAL Venture Lab. Proceeds will fund continued clinical development of the company's aortic portfolio, including patient follow-up in the AAA-SHAPE Pivotal Trial (IMPEDE-FX RapidFill®) and advancement of the FLAGSHIP first-in-human feasibility trial (False Lumen Embolization System for aortic dissection). AGP Partner Davian Sim is quoted on the platform's potential as the company reaches an inflection point across its clinical programs.", "tags": [ "portfolio", "healthcare", "medtech", "financing", "AGPHCF" ] }, { "date": "2026-07-30", "month_label": "July 2026", "source": "The Business Times", "title": "Ambiq Micro's SGX Secondary Listing a 'Reflection of Commitment'", "url": "https://www.businesstimes.com.sg/companies-markets/chip-designer-ambiq-micros-secondary-listing-sgx-reflection-commitment-ceo", "summary": "AGP portfolio company Ambiq Micro announces a secondary listing on the Singapore Exchange, complementing its existing NYSE listing. CEO Fumihide Esaka describes the move as a \"reflection of commitment\" to Singapore and the Asia-Pacific region, alongside a multi-year R&D programme in Singapore for Ambiq's sub-threshold power optimised (Spot) platform. The article notes August Global Partners among Ambiq's investors.", "tags": [ "portfolio", "advanced-manufacturing", "edge-AI", "AGPCGF" ] }, { "date": "2026-07-21", "month_label": "July 2026", "source": "Nikkei Asia", "title": "Singapore's Care Tech Race Heats Up as City-State Ages Rapidly", "url": "https://asia.nikkei.com/spotlight/asean-money/singapore-s-care-tech-race-heats-up-as-city-state-ages-rapidly", "summary": "Nikkei Asia features Singapore's rapidly growing eldercare technology ecosystem as the city-state becomes a super-aged society in 2026. AGP CEO Dr Basil Lui is quoted on what eldercare tech firms need to demonstrate to attract institutional private capital — \"clinical and economic efficacy, with hard diagnostic data that actively reduces overall hospital readmissions or long-term care costs, along with cross-border scalability of solutions across the region.\"", "tags": [ "thought-leadership", "healthcare", "eldercare", "Basil-Lui" ] }, { "date": "2026-06-01", "month_label": "June 2026", "source": "Bloomberg", "title": "Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Expansion", "url": "https://www.bloomberg.com/news/articles/2026-06-01/vietnam-genetic-testing-startup-eyes-hong-kong-ipo-to-fund-global-growth", "summary": "AGP portfolio company Gene Solutions prepares for a Hong Kong IPO as early as Q2 2027, targeting a valuation of around $800M. The Vietnamese genomics company aims to raise ~$100M through the listing, alongside completing a $50M Series C round by end of Q3 2026, to fund global expansion across emerging markets. AGP founding partner Dr Basil Lui featured in the article on Vietnam's emerging life sciences ecosystem.", "tags": [ "portfolio", "healthcare", "biotech", "IPO", "AGPHCF" ] }, { "date": "2026-05-15", "month_label": "May 2026", "source": "PR Newswire", "title": "Gene Solutions' SPOT-MAS 10 Receives FDA Breakthrough Device Designation", "url": "https://www.prnewswire.com/", "summary": "AGP portfolio company Gene Solutions receives FDA Breakthrough Device Designation for SPOT-MAS 10, its 10-cancer early detection blood test based on cell-free DNA methylation analysis.", "tags": [ "portfolio", "healthcare", "biotech", "FDA", "AGPHCF" ] }, { "date": "2026-05-10", "month_label": "May 2026", "source": "Investor's Business Daily", "title": "Ambiq Accelerates Sales Growth on Edge AI Demand", "url": "https://www.investors.com/", "summary": "AGP portfolio company Ambiq accelerates sales growth as edge AI demand drives adoption of its sub-threshold power optimised chips across smart devices and wearables.", "tags": [ "portfolio", "advanced-manufacturing", "edge-AI", "AGPCGF" ] }, { "date": "2026-03-15", "month_label": "March 2026", "source": "DealStreetAsia", "title": "AGP Featured in DealStreetAsia's SE Asia PE Funds H2 2025 Review", "url": "https://www.dealstreetasia.com/", "summary": "August Global Partners is featured in DealStreetAsia's semi-annual review of Southeast Asia's private equity fund landscape for H2 2025.", "tags": [ "firm", "recognition" ] }, { "date": "2026-02-15", "month_label": "February 2026", "source": "EDB Singapore", "title": "AGP Recognised as Tech@SG Pioneer / Recognised Investor", "url": "https://www.edb.gov.sg/", "summary": "August Global Partners is recognised as a Tech@SG Pioneer / Recognised Investor by Singapore's Economic Development Board.", "tags": [ "firm", "recognition", "Singapore" ] }, { "date": "2025-12-15", "month_label": "December 2025", "source": "Bloomberg", "title": "UltraGreen.ai IPO", "url": "https://www.bloomberg.com/", "summary": "AGP portfolio company UltraGreen.ai completes its IPO, marking another listing for the AGPCGF portfolio.", "tags": [ "portfolio", "clean-tech", "IPO", "AGPCGF" ] }, { "date": "2025-11-20", "month_label": "November 2025", "source": "PR Newswire", "title": "AGPHCF Closes at $150M", "url": "https://www.prnewswire.com/", "summary": "The AGP Healthcare Fund (AGPHCF) formally closes at US$150M, dedicated to the Living Better, Aging Better theme across precision medicine, diagnostics, medical technology, digital health, and healthcare services.", "tags": [ "firm", "fund-close", "AGPHCF" ] }, { "date": "2025-11-10", "month_label": "November 2025", "source": "Reuters", "title": "Gene Solutions Pre-IPO Round", "url": "https://www.reuters.com/", "summary": "Gene Solutions closes a pre-IPO financing round with participation from AGP and other institutional investors.", "tags": [ "portfolio", "healthcare", "biotech", "financing", "AGPHCF" ] }, { "date": "2025-09-15", "month_label": "September 2025", "source": "The Edge Singapore", "title": "65 Equity Partners UltraGreen.ai", "url": "https://www.theedgesingapore.com/", "summary": "65 Equity Partners and other investors participate in UltraGreen.ai financing alongside AGP.", "tags": [ "portfolio", "clean-tech", "financing", "AGPCGF" ] }, { "date": "2024-09-15", "month_label": "September 2024", "source": "DealStreetAsia", "title": "Basil Lui at PE-VC Summit", "url": "https://www.dealstreetasia.com/", "summary": "AGP Founding Partner and CEO Dr Basil Lui speaks at DealStreetAsia's PE-VC Summit on Southeast Asia healthcare investment themes.", "tags": [ "thought-leadership", "Basil-Lui", "firm" ] }, { "date": "2023-11-20", "month_label": "November 2023", "source": "Tech in Asia", "title": "Ex-EDBI Chief Launches $250M Firm", "url": "https://www.techinasia.com/", "summary": "August Global Partners launches under founding partners Chu Swee Yeok PBM (former EDBI CEO) and Dr Basil Lui, with an initial platform target of ~US$250M across two inaugural funds.", "tags": [ "firm", "launch", "AGPCGF", "AGPHCF" ] } ] }